Expensive and a life long prescription. I know someone that was doing a home injection and held the device the wrong way and shot the drug across the room.

Mike

Published cost-effectiveness analyses of GLP-1 receptor agonists for obesity and diabetes have shown mixed results, but their wide-ranging benefits may have been sold short.
— Read on www.medscape.com/viewarticle/994635